Loading...
RAPPER - A success story for collaborative translational radiotherapy research
Burnet, Neil G Barnett, G Summersgill, HR Dunning, AM West, Catharine ML
Burnet, Neil G
Barnett, G
Summersgill, HR
Dunning, AM
West, Catharine ML
Citations
Altmetric:
Abstract
RAPPER (Radiogenomics: Assessment of Polymorphisms for Predicting the Effects of Radiotherapy) is a success story for national collaborative translational science. The study was established with the aim of identifying genetic variants associated with a patient’s risk of developing radiotherapy side-effects that could be combined in a clinical test incorporating non-genetic risk factors to individualise treatment [1]. Underpinned by hypothesis-driven science, RAPPER collects blood to extract germline DNA from patients with high-quality clinical outcome data e collected mainly in national trials led by members of the UK clinical oncology community. It is an effort that we, as a community, should be very proud of. This editorial provides an update on the status of RAPPER and its future ambitions.
Description
Date
2019
Publisher
Collections
Keywords
Type
Article
Citation
Burnet NG, Barnett GC, Summersgill HR, Dunning AM, West CML. RAPPER - A success story for collaborative translational radiotherapy research. Clin Oncol. 2019;31(7):416-9.